OPKO Health, Inc. secures $125 million in additional notes issuance from HealthCare Royalty, expanding its financing relationship. This capital is aimed at strengthening its balance sheet and retaining value from its mazdutide royalties.
Amount Raised
$125 Million
Round Type
Debt Financing
MiamiBiotechnologyHealth CareBiopharmaInvestors
Description
OPKO Health, Inc. announced an expansion of its financing relationship with HealthCare Royalty through an additional $125 million notes issuance. These notes are secured by OPKO's royalty interests under its mazdutide license with Eli Lilly. This transaction is intended to provide non-dilutive capital while preserving long-term royalty participation
Quick answer
OPKO Health raised $125 Million in a Debt Financing round, dated August 13, 2026. Investors: HealthCare Royalty. OPKO Health is based in Miami, Florida, United States.
- How much did OPKO Health raise?
- OPKO Health raised $125 Million in a Debt Financing round on August 13, 2026.
- Who invested in OPKO Health?
- HealthCare Royalty is named as investors in this round.
- What does OPKO Health do?
- OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and..
- Where is OPKO Health based and how big is it?
- OPKO Health is based in Miami, Florida, United States. Fundz records about 3,000 employees.
- Who are the decision-makers at OPKO Health?
- Fundz holds 3 contacts at OPKO Health, including the Director, Project Management (PMO), Includes Operations and Supply Chain. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biopharma and Biotechnology around the same time
Companies in the same sectors as OPKO Health that raised within 45 days of this round, from Fundz verified event records.
- Tempest Therapeutics raised $7.5M on September 15, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- AusperBio raised $120M (Series C) on August 28, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
Who to call at OPKO Health, and when
A new round usually means OPKO Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OPKO Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OPKO Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OPKO Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OPKO Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OPKO Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.